NEW YORK, NY / ACCESS Newswire / March 25, 2025 / If you suffered a loss on your Zynex, Inc. (NASDAQ:ZYXI) investment and want to learn about a ...

Law Offices of Howard G. Smith reminds investors of the upcoming May 19, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Zynex, Inc. ("Zynex" or ...

A class action securities lawsuit was filed against Zynex, Inc. (ZYXI) that seeks to recover losses of Zynex, Inc. shareholders who ...

NEW YORK CITY, NY / ACCESS Newswire / March 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Glancy Prongay & Murray LLP reminds investors of the upcoming May 19, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired ...

Zynex specializes in non-invasive pain management and patient monitoring, with promising advancements. Read why I think ZYXI ...

The litigation is focused on the propriety of Zynex's statements about its sales and billing practices, its revenue recognition practices, and its relationship with the military health program for ...

Robbins LLP reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Zynex, Inc. (NASDAQ: ZYXI) securities between March 13, 2023 to ...

Fintel reports that on March 12, 2025, Ladenburg Thalmann downgraded their outlook for Zynex (NasdaqGS:ZYXI) from Buy to ...

Despite a net loss and TRICARE payment suspension, Zynex Inc (ZYXI) shows resilience with revenue growth and strategic ...

Zynex, Inc. (NASDAQ: ZYXI) ("Zynex", "ZMS", "we" or the "Company"), an innovative medical technology company specializing in the manufacture and sale of noninvasive medical devices for pain ...

ZYNEX ($ZYXI) posted quarterly earnings results on Tuesday, March 11th. The company reported earnings of -$0.02 per share, missing estimates of $0.09 by $0.11. The ...